SOURCE: NICOX

November 14, 2005 02:10 ET

NICOX : NicOx Conference call

Sophia-Antipolis cedex -- (MARKET WIRE) -- November 14, 2005 -- TO: Investors and Analysts

WHAT: NicOx S.A. will host a teleconference for investors and analysts to discuss NCX 4016 phase II results in Peripherial Arterial Obstructive Disease (PAOD) released today.

WHO: Michele Garufi, Chairman and CEO, NicOx S.A.

WHEN: Monday November 14th, 2005 - 3:00 pm CET time

DIAL-IN: +33 (0)1 56 38 35 35

A replay of this call will be available from 5:00 pm CET time, November 14 until November 22. To listen to the replay, dial +33 (0)1 70 99 32 95 - Pin code: 133616#

CONTACT:

Karl Hanks, Manager of Corporate Relations and Marketing Analysis

Tel +33 (0)4 97 15 22 03

hanks@nicox.com

Thanks for confirming your participation to Irène Lalande

Tel: +33 (0)4 97 15 21 85 / lalande@nicox.com

NicOx S.A.,

2455 route des Dolines, Espace Gaïa II, BP313, 06906 Sophia Antipolis cedex, France.

Tel. +33 (0)4 9238 7020 / Fax +33 (0)4 9238 7030

This information is provided by CompanynewsGroup

Contact Information